H T Hendricks1, A H Heeren2, P E Vos3. 1. Department of Rehabilitation Medicine, Radboud University Medical Centre, Nijmegen, Groot Klimmendaal, Rehabilitation Centre, Arnhem, the Netherlands. 2. Department of Rehabilitation Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands. 3. Radboud University Medical Centre, Institute of Neurology, Nijmegen, the Netherlands.
Abstract
BACKGROUND: Dysautonomia after traumatic brain injury (TBI) is characterized by episodes of increased heart rate, respiratory rate, temperature, blood pressure, muscle tone, decorticate or decerebrate posturing, and profuse sweating. This study addresses the incidence of dysautonomia after severe TBI, the clinical variables that are associated with dysautonomia, and the functional outcome of patients with dysautonomia. METHODS: A historic cohort study in patients with severe TBI [Glasgow Coma Scale (GCS) < or = 8 on admission]. RESULTS: Seventy-six of 119 patients survived and were eligible for follow-up. The incidence of dysautonomia was 11.8%. Episodes of dysautonomia were prevalent during a mean period of 20.1 days (range 3-68) and were often initiated by discomfort. Patients with dysautonomia showed significant longer periods of coma (24.78 vs. 7.99 days) and mechanical ventilation (22.67 vs. 7.21 days). Dysautonomia was associated with diffuse axonal injury (DAI) [relative risk (RR) 20.83, CI 4.92-83.33] and the development of spasticity (RR 16.94, CI 3.96-71.42). Patients with dysautonomia experienced more secondary complications. They tended to have poorer outcome. CONCLUSIONS: Dysautonomia occurs in approximately 10% of patients surviving severe TBI and is associated with DAI and the development of spasticity at follow-up. The initiation of dysautonomia by discomfort supports the Excitatory: Inhibitory Ratio model as pathophysiological mechanism.
BACKGROUND:Dysautonomia after traumatic brain injury (TBI) is characterized by episodes of increased heart rate, respiratory rate, temperature, blood pressure, muscle tone, decorticate or decerebrate posturing, and profuse sweating. This study addresses the incidence of dysautonomia after severe TBI, the clinical variables that are associated with dysautonomia, and the functional outcome of patients with dysautonomia. METHODS: A historic cohort study in patients with severe TBI [Glasgow Coma Scale (GCS) < or = 8 on admission]. RESULTS: Seventy-six of 119 patients survived and were eligible for follow-up. The incidence of dysautonomia was 11.8%. Episodes of dysautonomia were prevalent during a mean period of 20.1 days (range 3-68) and were often initiated by discomfort. Patients with dysautonomia showed significant longer periods of coma (24.78 vs. 7.99 days) and mechanical ventilation (22.67 vs. 7.21 days). Dysautonomia was associated with diffuse axonal injury (DAI) [relative risk (RR) 20.83, CI 4.92-83.33] and the development of spasticity (RR 16.94, CI 3.96-71.42). Patients with dysautonomia experienced more secondary complications. They tended to have poorer outcome. CONCLUSIONS:Dysautonomia occurs in approximately 10% of patients surviving severe TBI and is associated with DAI and the development of spasticity at follow-up. The initiation of dysautonomia by discomfort supports the Excitatory: Inhibitory Ratio model as pathophysiological mechanism.
Authors: Jonathan Marehbian; Susanne Muehlschlegel; Brian L Edlow; Holly E Hinson; David Y Hwang Journal: Neurocrit Care Date: 2017-12 Impact factor: 3.210
Authors: Katherine A Kirk; Michael Shoykhet; Jong H Jeong; Elizabeth C Tyler-Kabara; Maryanne J Henderson; Michael J Bell; Ericka L Fink Journal: Dev Med Child Neurol Date: 2012-06-19 Impact factor: 5.449
Authors: Elke Pucks-Faes; Gabriel Hitzenberger; Heinrich Matzak; Giulio Verrienti; Robert Schauer; Leopold Saltuari Journal: Brain Behav Date: 2018-09-28 Impact factor: 2.708
Authors: João Gustavo Rocha Peixoto Dos Santos; Ana Luiza Costa Zaninotto; Renato Amaro Zângaro; Ana Maria Costa Carneiro; Iuri Santana Neville; Almir Ferreira de Andrade; Manoel Jacobsen Teixeira; Wellingson Silva Paiva Journal: Trials Date: 2018-04-24 Impact factor: 2.279